Titlebook: Incentives for Research, Development, and Innovation in Pharmaceuticals; Walter García-Fontes Textbook 2011 Springer Healthcare Iberica, S

Pessimistic

書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals影響因子(影響力)




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals影響因子(影響力)學(xué)科排名




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals網(wǎng)絡(luò)公開度




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals被引頻次




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals被引頻次學(xué)科排名




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals年度引用




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals年度引用學(xué)科排名




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals讀者反饋




書目名稱Incentives for Research, Development, and Innovation in Pharmaceuticals讀者反饋學(xué)科排名

預(yù)定

,The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982–2003,ber of global, first-in-class, biotech and orphan drugs exhibited more positive trends. U.S. headquartered firms also assumed a strong leadership position in terms of being the initial introducers of the most novel compounds including first-in-class, biotech and orphan drugs.

澄清

When patents are not enough: Supplementary incentives for pharmaceutical innovation, where for some reason the value of the patent reward is relatively low compared to the social value created by the innovation: that is, where the . of social value is low. In these cases, firms will fail to invest in innovation even though its value to society is high.

召集

拱形大橋

jet-lag

除草劑

燦爛

Textbook 2011 size of the markets being targeted and the incentives being provided. Patents become an ineffective way to incentivise R&D when the appropriability is low; this book provides alternative ideas such as allowing for a period of data exclusivity to firms that develop new drugs.

CLOT

自愛

Aidan Hollisut program into a sequence of steps in a machine program, and they then describe the interfaces between the modules. Finally, the structures of real translators are outlined. The book contains the necessary theory and advice for implementation..?.This book is intended for students of computer scienc